Patient Characteristics and Persistence Among Commercially Insured Patients With Multiple Sclerosis Initiating Cladribine Tablets

被引：0
|
作者：
Kozma, Chris [1 ]
Evans, Emily [2 ]
Lebson, Lori [2 ]
Phillips, Amy [2 ]
Lobo, Carroline [2 ]
机构：
[1] CK Consulting Associates LLC, Baton Rouge, LA USA
[2] EMD Serono Inc, Rockland, MA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203948
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P14-3.001
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey
    Koseoglu, Mesrure
    Omerhoca, Sami
    Balci, Fatma Belgin
    Unal, Aysun
    Ozdemir, Zeynep
    Yuksel, Burcu
    Celik, Rabia Gokcen Gozubatik
    Toprak, Ufuk Emre
    Gursoy, Esra Azize
    Icen, Nilufer Kale
    Altunrende, Burcu
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1017 - 1017
  • [42] HEALTH STATE UTILITIES IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS TREATED WITH CLADRIBINE TABLETS
    Wong, S. L.
    Hohnhorst, P., V
    Hettle, R.
    Konings, P.
    VALUE IN HEALTH, 2017, 20 (09) : A725 - A725
  • [43] Demonstrating the value of a patient support program for multiple sclerosis patients prescribed cladribine tablets in ireland at the end of year 1
    Morgan, K.
    Joseph, B.
    Williams, V.
    Kelly, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 599 - 599
  • [44] Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets
    Giovannoni, Gavin
    Coyle, Patricia K.
    Vermersch, Patrick
    Walker, Bryan
    Aldridge, Julie
    Nolting, Axel
    Galazka, Andrew
    Lemieux, Caroline
    Leist, Thomas P.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [45] Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis
    Comi, Giancarlo
    Cook, Stuart
    Giovannoni, Gavin
    Rieckmann, Peter
    Sorensen, Per Soelberg
    Vermersch, Patrick
    Galazka, Andrew
    Nolting, Axel
    Hicking, Christine
    Dangond, Fernando
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 29 : 168 - 174
  • [46] Reduced grey matter atrophy in patients with relapsing multiple sclerosis treated with cladribine tablets
    Battaglini, M.
    Sormani, M. P.
    Luchetti, L.
    Gentile, G.
    Cortese, R.
    Alexandri, N.
    De Stefano, N.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 231 - 231
  • [47] Cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis of safety from the multiple sclerosis clinical development program
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Sylvester, E.
    Hicking, C.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 305 - 306
  • [48] Analysis of Lymphocyte Subsets in Younger and Older Patients with Multiple Sclerosis Treated with Cladribine Tablets
    Giovannoni, G.
    Coyle, P. K.
    Vermersch, P.
    Walker, B.
    Aldridge, J.
    Nolting, A.
    Galazka, A.
    Lemieux, C.
    Leist, T. P.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 44 - 44
  • [49] Multiple sclerosis prevalence in the United States commercially insured population
    Dilokthornsakul, Piyameth
    Valuck, Robert J.
    Nair, Kavita V.
    Corboy, John R.
    Allen, Richard R.
    Campbell, Jonathan D.
    NEUROLOGY, 2016, 86 (11) : 1014 - 1021
  • [50] PERSISTENCE AND ADHERENCE OF ANTIFIBROTIC MEDICATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS IN A COMMERCIALLY INSURED PATIENT POPULATION
    Corral, Mitra
    DeYoung, Kathryn
    Kong, Amanda
    CHEST, 2019, 156 (04) : 437A - 437A
12345